Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Eur J Ophthalmol ; : 11206721241230567, 2024 Feb 04.
Artigo em Inglês | MEDLINE | ID: mdl-38311887

RESUMO

INTRODUCTION: There are no reports in the literature studying the possible relationship between Epstein-Barr virus (EBV) and optic nerve involvement in multiple sclerosis (MS). The aim of our study was to analyze the association between EBV antibodies titres and optical coherence tomography (OCT) and OCT angiography (OCTA) quantitative parameters. METHODS: We conducted a retrospective study. The study included 98 eyes of 49 patients with MS. Years of MS duration, relapse count, history of optic neuritis (ON), and immunoglobulin (Ig) G antibodies to the EBV viral capsid antigen (VCA) were recorded from each patient. Also, OCT analysis (including retinal nerve fibre layer (RNFL) thickness and ganglion cell-inner plexiform layer (GCIPL) thickness) and OCTA analysis (including perfusion density (PD) and flux index (FI) of the radial peripapillary capillary plexus) were performed in each participant. RESULTS: No significant associations were observed between anti-EBV antibody levels and OCT or OCTA parameters (p > 0,05). Correlation analysis between OCT and OCTA measurements showed a significant positive correlation between RNFL thickness and GCIPL thickness with peripapillary PD and FI (p < 0,035). Subgroup analysis revealed a significant diminution of RNFL thickness, GCIPL thickness and peripapillary PD and FI (p < 0,05) in the ON group. CONCLUSION: We were unable to demonstrate a significant association between anti-EBV VCA IgG antibody titres and OCT or OCTA parameters. Nonetheless, further longitudinal studies are needed to explore the possible association of EBV with optic nerve involvement in MS.

2.
Eur J Ophthalmol ; : 11206721241228349, 2024 Jan 23.
Artigo em Inglês | MEDLINE | ID: mdl-38258450

RESUMO

INTRODUCTION: Evidence on peripapillary microvasculature in intracranial hypertension (IH) after the regression of papilledema is still scarce. The aim of this preliminary study was to determine the association between structural changes in the optic nerve and the retina and peripapillary microvasculature in patients with IIH. METHODS: We conducted a retrospective study. The study included 39 eyes of 21 patients with IIH. Treatment for IIH and history of obesity were registered from each patient. Moreover, OCT analysis including retinal nerve fiber layer (RNFL) thickness and ganglion cell-inner plexiform layer (GCIPL) thickness, and OCTA analysis including perfusion density (PD) and flux index (FI) of the radial peripapillary capillary plexus were performed. RESULTS: Correlation analysis revealed a high correlation between GCIPL thickness and peripapillary PD and FI (p < 0,05, r > 0,7), whereas the degree of correlation between RNFL thickness and peripapillary microvascular parameters was low (p < 0,05, r < 0,7). Patients with regressed papilledema had significantly lower GCIPL thickness and peripapillary PD than control subjects (p < 0,05). CONCLUSION: Peripapillary microvascular measurements are highly correlated with GCIPL thickness in patients with IIH. Moreover, GCIPL thickness and peripapillary PD are significantly inferior in patients with regressed papilledema compared to control group. Thus, we suggested that peripapillary microvascular parameters may be an early indicator of optic nerve atrophy in patients with IIH.

3.
Optom Vis Sci ; 99(10): 781-785, 2022 10 01.
Artigo em Inglês | MEDLINE | ID: mdl-36067394

RESUMO

SIGNIFICANCE: Optic neuropathy associated with Sjögren syndrome is rare and usually has an acute onset. PURPOSE: This study aimed to report a case of asymmetric optic nerve atrophy attributed to Sjögren syndrome. CASE REPORT: A 37-year-old woman was referred to neuro-ophthalmology service because of right optic nerve atrophy of unknown etiology. The patient was asymptomatic. Best-corrected visual acuity was 20/200 Snellen equivalent in the right eye and 20/20 Snellen equivalent in the left eye. The right eye had a relative afferent pupillary defect. Visual field demonstrated dense temporal loss, superior arcuate involvement, and an inferior paracentral defect in the right eye. Slit-lamp examination showed mild fluorescein staining of the cornea, moderate lissamine green staining of the conjunctiva, and abnormal tear breakup time in both eyes. Fundus examination revealed diffuse pallor of the right optic disc and a normal left optic disc. Optical coherence tomography showed inferior and superior retinal nerve fiber layer atrophy in the right eye and inferior retinal nerve fiber layer atrophy in the left eye. A diagnosis of right optic nerve atrophy was made. Immunologic studies were significant for positive anti-Ro and anti-La antibodies. MRI of the brain and orbit ruled out any intracranial or white-matter pathology. A diagnosis of optic nerve atrophy secondary to Sjögren syndrome was suspected, so corticosteroid treatment was started. CONCLUSIONS: Optic nerve atrophy may be the initial manifestation of Sjögren syndrome. Therefore, optic neuropathy associated with Sjögren syndrome remains a diagnostic challenge. In these cases, specific antibodies such as anti-Ro and anti-La facilitate early diagnosis and can prevent vision-threatening complications.


Assuntos
Atrofia Óptica , Doenças do Nervo Óptico , Síndrome de Sjogren , Adulto , Atrofia , Feminino , Fluoresceínas , Humanos , Atrofia Óptica/diagnóstico , Atrofia Óptica/etiologia , Nervo Óptico/diagnóstico por imagem , Doenças do Nervo Óptico/diagnóstico , Síndrome de Sjogren/complicações , Síndrome de Sjogren/diagnóstico , Tomografia de Coerência Óptica/métodos
7.
Rev. esp. drogodepend ; 39(3): 107-112, jul.-sept. 2014. tab
Artigo em Espanhol | IBECS | ID: ibc-127113

RESUMO

Los trastornos relacionados con el uso del alcohol (TRUA) son una importante fuentede morbimortalidad. Multiplican por tres la mortalidad temprana global y son responsables del 6,5% de las muertes totales enla Unión Europea (Rehm et al., 2009). Se estima que en este mismo ámbito geográfico, 15 millones de personas son dependientes del alcohol (Rehm et al., 2009) y un número sin duda mayor abusarán del mismo, pero sólo un 10% reciben tratamiento (Alonso et al., 2004)


No disponible


Assuntos
Humanos , Alcoolismo/tratamento farmacológico , Dissuasores de Álcool/uso terapêutico , Consumo de Bebidas Alcoólicas/epidemiologia , Antagonistas de Entorpecentes/uso terapêutico , Naltrexona/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA